Naloxone Market
Naloxone Market - Global Industry Assessment & Forecast
#
Pages:
Base Year:
2022
Sep - 2023
Format:
Report Code:
VMR-VMR-2021-0530
Segments Covered
By
Route of Administration Injectables, Nasal, Oral
-
By
Strength 0.02mg/ml, 1mg/ml, 0.4mg/ml, Others
-
By
Distribution channel Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 1119.6 Million |
 Revenue 2030:
|
USD 2617.6 Million |
 Revenue CAGR
(2023 - 2030): |
11.2% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Naloxone Market Segment Analysis
- Naloxone Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
- Injectables
- Nasal
- Oral
- Naloxone Strength Outlook (Revenue, USD Million, 2018 - 2030)
- 0.02mg/ml
- 1mg/ml
- 0.4mg/ml
- Others
- Naloxone Distribution channel Outlook (Revenue, USD Million, 2018 - 2030)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Naloxone Market, by Route of Administration
- Injectables
- Nasal
- Oral
-
North America Naloxone Market, by Strength
- 0.02mg/ml
- 1mg/ml
- 0.4mg/ml
- Others
-
North America Naloxone Market, by Distribution channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- U.S.
- U.S. Naloxone Market, by Route of Administration
- Injectables
- Nasal
- Oral
- U.S. Naloxone Market, by Strength
- 0.02mg/ml
- 1mg/ml
- 0.4mg/ml
- Others
- U.S. Naloxone Market, by Distribution channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- U.S. Naloxone Market, by Route of Administration
- Canada
- Canada Naloxone Market, by Route of Administration
- Injectables
- Nasal
- Oral
- Canada Naloxone Market, by Strength
- 0.02mg/ml
- 1mg/ml
- 0.4mg/ml
- Others
- Canada Naloxone Market, by Distribution channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- Canada Naloxone Market, by Route of Administration
-
Mexico
- Mexico Naloxone Market, by Route of Administration
- Injectables
- Nasal
- Oral
- Mexico Naloxone Market, by Strength
- 0.02mg/ml
- 1mg/ml
- 0.4mg/ml
- Others
- Mexico Naloxone Market, by Distribution channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- Mexico Naloxone Market, by Route of Administration
-
North America Naloxone Market, by Route of Administration
- Europe
-
Europe Naloxone Market, by Route of Administration
- Injectables
- Nasal
- Oral
-
Europe Naloxone Market, by Strength
- 0.02mg/ml
- 1mg/ml
- 0.4mg/ml
- Others
-
Europe Naloxone Market, by Distribution channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- U. K.
- U.K. Naloxone Market, by Route of Administration
- Injectables
- Nasal
- Oral
- U.K. Naloxone Market, by Strength
- 0.02mg/ml
- 1mg/ml
- 0.4mg/ml
- Others
- U.K. Naloxone Market, by Distribution channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- U.K. Naloxone Market, by Route of Administration
- France
- France Naloxone Market, by Route of Administration
- Injectables
- Nasal
- Oral
- France Naloxone Market, by Strength
- 0.02mg/ml
- 1mg/ml
- 0.4mg/ml
- Others
- France Naloxone Market, by Distribution channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- France Naloxone Market, by Route of Administration
-
Germany
- Germany Naloxone Market, by Route of Administration
- Injectables
- Nasal
- Oral
- Germany Naloxone Market, by Strength
- 0.02mg/ml
- 1mg/ml
- 0.4mg/ml
- Others
- Germany Naloxone Market, by Distribution channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- Germany Naloxone Market, by Route of Administration
-
Italy
- Italy Naloxone Market, by Route of Administration
- Injectables
- Nasal
- Oral
- Italy Naloxone Market, by Strength
- 0.02mg/ml
- 1mg/ml
- 0.4mg/ml
- Others
- Italy Naloxone Market, by Distribution channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- Italy Naloxone Market, by Route of Administration
-
Spain
- Spain Naloxone Market, by Route of Administration
- Injectables
- Nasal
- Oral
- Spain Naloxone Market, by Strength
- 0.02mg/ml
- 1mg/ml
- 0.4mg/ml
- Others
- Spain Naloxone Market, by Distribution channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- Spain Naloxone Market, by Route of Administration
-
Rest of Europe
- Rest of Europe Naloxone Market, by Route of Administration
- Injectables
- Nasal
- Oral
- Rest of Europe Naloxone Market, by Strength
- 0.02mg/ml
- 1mg/ml
- 0.4mg/ml
- Others
- Rest of Europe Naloxone Market, by Distribution channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- Rest of Europe Naloxone Market, by Route of Administration
-
Europe Naloxone Market, by Route of Administration
- Asia Pacific
-
Asia Pacific Naloxone Market, by Route of Administration
- Injectables
- Nasal
- Oral
-
Asia Pacific Naloxone Market, by Strength
- 0.02mg/ml
- 1mg/ml
- 0.4mg/ml
- Others
-
Asia Pacific Naloxone Market, by Distribution channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- China
- China Naloxone Market, by Route of Administration
- Injectables
- Nasal
- Oral
- China Naloxone Market, by Strength
- 0.02mg/ml
- 1mg/ml
- 0.4mg/ml
- Others
- China Naloxone Market, by Distribution channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- China Naloxone Market, by Route of Administration
- Japan
- Japan Naloxone Market, by Route of Administration
- Injectables
- Nasal
- Oral
- Japan Naloxone Market, by Strength
- 0.02mg/ml
- 1mg/ml
- 0.4mg/ml
- Others
- Japan Naloxone Market, by Distribution channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- Japan Naloxone Market, by Route of Administration
-
Germany
- Germany Naloxone Market, by Route of Administration
- Injectables
- Nasal
- Oral
- Germany Naloxone Market, by Strength
- 0.02mg/ml
- 1mg/ml
- 0.4mg/ml
- Others
- Germany Naloxone Market, by Distribution channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- Germany Naloxone Market, by Route of Administration
-
India
- India Naloxone Market, by Route of Administration
- Injectables
- Nasal
- Oral
- India Naloxone Market, by Strength
- 0.02mg/ml
- 1mg/ml
- 0.4mg/ml
- Others
- India Naloxone Market, by Distribution channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- India Naloxone Market, by Route of Administration
-
South Korea
- South Korea Naloxone Market, by Route of Administration
- Injectables
- Nasal
- Oral
- South Korea Naloxone Market, by Strength
- 0.02mg/ml
- 1mg/ml
- 0.4mg/ml
- Others
- South Korea Naloxone Market, by Distribution channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- South Korea Naloxone Market, by Route of Administration
-
South East Asia
- South East Asia Naloxone Market, by Route of Administration
- Injectables
- Nasal
- Oral
- South East Asia Naloxone Market, by Strength
- 0.02mg/ml
- 1mg/ml
- 0.4mg/ml
- Others
- South East Asia Naloxone Market, by Distribution channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- South East Asia Naloxone Market, by Route of Administration
-
Rest of Asia Pacific
- Rest of Asia Pacific Naloxone Market, by Route of Administration
- Injectables
- Nasal
- Oral
- Rest of Asia Pacific Naloxone Market, by Strength
- 0.02mg/ml
- 1mg/ml
- 0.4mg/ml
- Others
- Rest of Asia Pacific Naloxone Market, by Distribution channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- Rest of Asia Pacific Naloxone Market, by Route of Administration
-
Asia Pacific Naloxone Market, by Route of Administration
- Latin America
-
Latin America Naloxone Market, by Route of Administration
- Injectables
- Nasal
- Oral
-
Latin America Naloxone Market, by Strength
- 0.02mg/ml
- 1mg/ml
- 0.4mg/ml
- Others
-
Latin America Naloxone Market, by Distribution channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- Brazil
- Brazil Naloxone Market, by Route of Administration
- Injectables
- Nasal
- Oral
- Brazil Naloxone Market, by Strength
- 0.02mg/ml
- 1mg/ml
- 0.4mg/ml
- Others
- Brazil Naloxone Market, by Distribution channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- Brazil Naloxone Market, by Route of Administration
- Argentina
- Argentina Naloxone Market, by Route of Administration
- Injectables
- Nasal
- Oral
- Argentina Naloxone Market, by Strength
- 0.02mg/ml
- 1mg/ml
- 0.4mg/ml
- Others
- Argentina Naloxone Market, by Distribution channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- Argentina Naloxone Market, by Route of Administration
-
Rest of Latin America
- Rest of Latin America Naloxone Market, by Route of Administration
- Injectables
- Nasal
- Oral
- Rest of Latin America Naloxone Market, by Strength
- 0.02mg/ml
- 1mg/ml
- 0.4mg/ml
- Others
- Rest of Latin America Naloxone Market, by Distribution channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- Rest of Latin America Naloxone Market, by Route of Administration
-
Latin America Naloxone Market, by Route of Administration
- Middle East & Africa
-
Middle East & Africa Naloxone Market, by Route of Administration
- Injectables
- Nasal
- Oral
-
Middle East & Africa Naloxone Market, by Strength
- 0.02mg/ml
- 1mg/ml
- 0.4mg/ml
- Others
-
Middle East & Africa Naloxone Market, by Distribution channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- GCC Countries
- GCC Countries Naloxone Market, by Route of Administration
- Injectables
- Nasal
- Oral
- GCC Countries Naloxone Market, by Strength
- 0.02mg/ml
- 1mg/ml
- 0.4mg/ml
- Others
- GCC Countries Naloxone Market, by Distribution channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- GCC Countries Naloxone Market, by Route of Administration
- South Africa
- South Africa Naloxone Market, by Route of Administration
- Injectables
- Nasal
- Oral
- South Africa Naloxone Market, by Strength
- 0.02mg/ml
- 1mg/ml
- 0.4mg/ml
- Others
- South Africa Naloxone Market, by Distribution channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- South Africa Naloxone Market, by Route of Administration
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Naloxone Market, by Route of Administration
- Injectables
- Nasal
- Oral
- Rest of Middle East & Africa Naloxone Market, by Strength
- 0.02mg/ml
- 1mg/ml
- 0.4mg/ml
- Others
- Rest of Middle East & Africa Naloxone Market, by Distribution channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- Rest of Middle East & Africa Naloxone Market, by Route of Administration
-
Middle East & Africa Naloxone Market, by Route of Administration
- North America
FAQ
Frequently Asked Question
What is the global demand for Naloxone in terms of revenue?
-
The global Naloxone valued at USD 1119.6 Million in 2022 and is expected to reach USD 2617.6 Million in 2030 growing at a CAGR of 11.2%.
Which are the prominent players in the market?
-
The prominent players in the market are Pfizer,West Ward Pharmaceuticals,Amneal Pharmaceuticals,Sandoz,ADAPT Pharma,Mylan,kaleo,Amphastar Pharmaceuticals.
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 11.2% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Naloxone include
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Naloxone in 2022.
